MedTrace Logo

Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)

NCT03848052 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75000

Last updated 2026-05-27

No results posted yet for this study

Summary

This database compiles data from existing data available from patient's electronic medical records (EMR) at the 38 participating hospitals (20 French comprehensive cancer centers and 18 public hospitals).

Conditions

Sponsors & Collaborators

Principal Investigators

  • Anne-Laure Martin, Pharmacist · UNICANCER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-02
Primary Completion
2025-10-24
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03848052 on ClinicalTrials.gov